ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 18 of 45
Up
УЖМБС 2021, 6(6): 148–151
https://doi.org/10.26693/jmbs06.06.148
Clinical Medicine

Comparative Pharmacotherapy of Hypertension

Meretskyi V., Meretska I.
Abstract

The purpose of the study. This study aims to review the practice of the utilization of antihypertensive drugs of various pharmacological groups within the condition of the therapeutic hospital in Ukrainian and Egyptian patients, adherence to treatment in patients with hypertension in Ukraine and Egypt. Materials and methods. A study of 120 patients who were treated for hypertension II stage in a therapeutic hospital in Ternopil and Cairo was conducted. All subjects completed a questionnaire that included personal, socio-demographic, and medical data. The number and type of hypotensive drugs or drug combinations were analyzed. Results and discussion. Regarding the pharmacotherapy of hypertension the use of β-blockers among Ukrainian participants did not differ from Egyptian. The use of calcium channel antagonists was a little bit higher among Egyptians than Ukrainians. Diuretics were used more often by Ukrainians than by Egyptians. The use of ACEI/ARBs surpassed the use of all other classes of antihypertensives among both groups. Whereas the ACEI/ARBs use among Egyptians was lower than Ukrainians. In this study we conducted a determination of compliance which was defined as an act of adhering to the regimen of care recommended by the clinician and persisting with it over time. The majority of Ukrainian and Egyptian patients with hypertension do not always perform the doctor's prescription. The reason for the unfull implementation of medical prescriptions with the same frequency was called deficiency of funds and forgetfulness. Near 80% of Ukrainian respondents are ready to complete the prescription with understanding, however, 14% of the patients stated that they were not always ready to fulfill the prescription, and the smallest part of patients did not think it was necessary to follow the regularity of treatment and treatment regimen. We noted no significant difference in the adherence to antihypertensive therapy between Ukrainian and Egyptian participants. Early discontinuation of treatment and suboptimal daily use of the prescribed regimens are the foremost common facets of poor adherence to treatment as well as non-adherence to antihypertensive therapy correlates with a better risk of cardiovascular events. Conclusion. ACEI/ARBs are the most commonly used group of antihypertensive drugs among Ukrainian and Egyptian patients. The majority of Ukrainian and Egyptian participants with hypertension do not always perform the doctor's prescription. Only 50% had an objective reason for insufficient compliance

Keywords: hypertension, antihypertensive drugs, pharmacotherapy, treatment regimen, compliance

Full text: PDF (Ua) 266K

References
  1. Huffman MD, Lloyd-Jones DM. Global burden of raised blood pressure: Coming into focus. JAMA. 2017 Jan 10; 317: 142. https://www.ncbi.nlm.nih.gov/pubmed/28097343. https://doi.org/10.1001/jama.2016.19685
  2. Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure (SPRINT Study Research Group). Hypertension. 2017; 69: 42-50. https://www.ncbi.nlm.nih.gov/pubmed/27849563. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5145774. https://doi.org/10.1161/hypertensionaha.116.08076
  3. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018; 36: 1953-2041.
  4. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 1345-1422. https://doi.org/10.1016/S0140-6736(17)32366-8
  5. Williams B, Mancia G, Spiering W, et al. ESC Scientific Document Group. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39: 3021-3104. https://www.ncbi.nlm.nih.gov/pubmed/30165516. https://doi.org/10.1093/eurheartj/ehy339
  6. Assaad-Khalil SH, Nashaat N. Real-life effectiveness and safety of amlodipine/valsartan single-pill combination in patients with hypertension in Egypt: results from the EXCITE study. Drugs - Real World Outcomes. 2016; 3: 307-315. https://www.ncbi.nlm.nih.gov/pubmed/27747834. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5042938. https://doi.org/10.1007/s40801-016-0082-5
  7. Awad EY, Gwaied BE, Fouda LM, El-Gamelen HA. Compliance of hypertensive patients with treatment regimen and its effect on their quality of life. J Nurs Health Sci. 2015 Mar.-Apr.; 4 (2): 26-36.
  8. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75:1334-1357. https://www.ncbi.nlm.nih.gov/pubmed/32370572. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
  9. Hardy S, Chen L, Cherrington A, et al. Racial and ethnic differences in blood pressure among US adults, 1999-2018. Hypertension. 2021; 78: 1730-1741. https://www.ncbi.nlm.nih.gov/pubmed/34719937. https://doi.org/10.1161/HYPERTENSIONAHA.121.18086
  10. Guirguis-Blake J, Evans C, Webber E, Coppola EL, Perdue LA, Weyrich MS. Screening for hypertension in adults. Updated evidence report and systematic review for the US preventive services task force. JAMA. 2021; 325(16): 1657-1669. https://www.ncbi.nlm.nih.gov/pubmed/33904862. https://doi.org/10.1001/jama.2020.21669